ARCHIVES

Immunotherapy Demonstrates Disease Control in Phase II Study

This article is from The Cancer Letter archive.

Vol. 35 No. 9 | September 28, 2012

Download PDF Visit The Full Archive

Related Articles

New Test Predicts Breast Cancer Recurrence And Who Benefits Most From Chemotherapy

December 31, 2004

“Realistic” Bypass Budget For 1983 asks $1.147Billion; Organ Site, Training, Control Would Get No Increases

September 18, 1981

FDA Warns of Lymphoma Risk Associated With Breast Implants

January 28, 2011

Three cancer centers joined the Multiple Myeloma Research Consortium.

September 16, 2005

Data collection Completed In NCI Study of BRACA1

August 16, 1996

Almost Half of Faculty on IRBs Have Industry Ties, Study Finds

September 26, 2003